All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @drleprovost on TikTok · 11s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @drleprovost's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Now whenever you do the injection, you've got to be sure that your course year at spot
  2. 0:02is clean, that you're getting regular routine blood work, and also that you're using of course
  3. 0:08certified pharmaceutical grade testosterone.

@drleprovost's TRT safety tips pass the fact-check

Dr. Le Provost NMD

TikTok creator

348.0K viewsWatch on TikTok

Quick answer

Testosterone replacement therapy via injection carries documented risks including erythrocytosis, injection site infection, and hormonal imbalance that require structured monitoring per Endocrine Society 2018 guidelines. The creator's three recommendations align with minimum safety standards for self-administered injectable testosterone. Patients should understand that blood work monitoring is time-sensitive, particularly hematocrit surveillance in the first 6 months of therapy.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @drleprovost's TRT safety tips pass the fact-check, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@drleprovost's TRT safety tips pass the fact-check should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@drleprovost's TRT safety tips pass the fact-check" from Dr. Le Provost NMD. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Testosterone replacement therapy via injection carries documented risks including erythrocytosis, injection site infection, and hormonal imbalance that require structured monitoring per Endocrine Society 2018 guidelines.

The reason this review is not generic is the source wording and the canonical claim label "trt when doing testosterone therapy and using injections make s." In this clip, the useful excerpt is: "Now whenever you do the injection, you've got to be sure that your course year at spot is clean, that you're getting regular routine blood work, and also that you're using of course certified pharmaceutical grade testosterone." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Home injection infection risk is real: Fink et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Testosterone replacement therapy via injection carries documented risks including erythrocytosis, injection site infection, and hormonal imbalance that require structured monitoring per Endocrine Society 2018 guidelines.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Testosterone replacement therapy via injection carries documented risks including erythrocytosis, injection site infection, and hormonal imbalance that require structured monitoring per Endocrine Society 2018 guidelines. The creator's three recommendations align with minimum safety standards for self-administered injectable testosterone. Patients should understand that blood work monitoring is time-sensitive, particularly hematocrit surveillance in the first 6 months of therapy.
  • The Endocrine Society 2018 guideline recommends hematocrit monitoring at 3 months, 6 months, and annually during testosterone therapy to catch polycythemia early.
  • Home injection infection risk is real: Fink et al. (2019) identified skin preparation and sterile needle use as under-discussed safety factors in self-administered TRT.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The Endocrine Society 2018 guideline recommends hematocrit monitoring at 3 months, 6 months, and annually during testosterone therapy to catch polycythemia early.
  • Home injection infection risk is real: Fink et al. (2019) identified skin preparation and sterile needle use as under-discussed safety factors in self-administered TRT.
  • Van der Nagel et al. (2014) found significant concentration variability and contamination in seized anabolic steroid products, supporting the case against unregulated testosterone sources.
  • In the US, testosterone is a Schedule III controlled substance. Obtaining it without a valid prescription from a licensed provider is a legal and safety issue.
  • Compounded testosterone from a 503A pharmacy is not FDA-approved and is not equivalent to brand-name pharmaceutical products. Patients should understand this distinction.
  • Estradiol levels warrant monitoring alongside testosterone because testosterone aromatizes to estrogen, and imbalances have documented effects on mood, libido, and cardiovascular markers.
  • Rotating injection sites matters beyond cleanliness: repeated injection at the same site causes lipohypertrophy, which impairs absorption and complicates dosing consistency.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @drleprovost actually say?

The advice here is pretty concise. @drleprovost tells viewers three things to do when injecting testosterone: keep the injection site clean, get regular blood work, and use "certified pharmaceutical grade testosterone" rather than unverified sources. That's essentially the whole message. No dosing claims, no cure claims, no stacking recommendations. For a TikTok aimed at a general audience, the scope is narrow and practical.

Worth noting: the caption mentions "don't buy it off the street," which the transcript softens to just using pharmaceutical grade testosterone. Either framing is pointing at the same real risk, which is counterfeit or contaminated testosterone from unregulated sources. It's a legitimate concern and one that gets underplayed in online TRT communities.

Does the science back this up?

Yes, on all three points, the evidence is solid. This isn't a controversial take. These are standard-of-care recommendations repeated in clinical guidelines from the Endocrine Society and the American Urological Association.

On injection site hygiene: intramuscular and subcutaneous injections carry a real infection risk when done at home without sterile technique. A 2019 review by Fink et al. in Translational Andrology and Urology specifically flagged skin preparation and sterile needle use as under-discussed but important safety factors in self-administered TRT. Abscess formation and cellulitis from contaminated injection sites are documented complications, not theoretical ones.

On blood work: testosterone therapy shifts hematocrit, red blood cell mass, and can affect lipid panels and PSA levels. The Endocrine Society's 2018 clinical practice guideline recommends monitoring hematocrit at 3 and 6 months initially, then annually. Skipping labs isn't a personal choice issue here, it's how you catch polycythemia before it causes a clot.

On pharmaceutical grade testosterone: counterfeit anabolic steroids and testosterone products are well-documented. A 2014 study by van der Nagel et al. in Drug Testing and Analysis found significant concentration variability and contamination in seized anabolic steroid products. Using unverified sources means you don't know what you're injecting.

What did they get wrong (or right)?

Honestly? They got the basics right. There's nothing clinically wrong in this video. The advice is accurate, appropriately brief, and doesn't overstep into dosing or disease-cure territory. Credit where it's due.

The one real criticism is what's missing rather than what's wrong. "Regular routine blood work" is vague. Viewers watching this who are new to TRT may not know that hematocrit monitoring is specifically time-sensitive, or that estradiol levels also warrant tracking given testosterone's aromatization to estrogen. Saying "get blood work" without any scaffolding around what or when leaves a gap that a motivated viewer will fill with whatever Reddit thread they find first.

The phrase "certified pharmaceutical grade" is also slightly imprecise. In the US, testosterone is a Schedule III controlled substance dispensed through licensed pharmacies, and there's no separate "certification" tier for pharmaceutical grade in the way the phrase might imply. Compounded testosterone from licensed 503A pharmacies is not equivalent to FDA-approved brand-name products. Viewers should understand that distinction when seeking care.

What should you actually know?

If you're on or considering TRT via injection, the three points in this video are a reasonable floor, not a ceiling. Clean injection technique matters and includes more than just a clean spot: it means a new needle every time, proper skin prep with alcohol and letting it dry, and rotating injection sites to prevent lipohypertrophy.

Blood work cadence matters more than just frequency. Early in therapy, labs at 3 months catch problems before they compound. A one-time annual check after years of stable therapy is different from skipping monitoring entirely in your first year. Talk to your prescriber about what panel makes sense for your situation.

And on sourcing: in the US, testosterone requires a prescription. If someone is selling it without one, or if a telehealth platform is not collecting labs and doing proper intake, those are red flags regardless of how pharmaceutical the product looks. Regulatory status matters for patient safety, not just legal compliance.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. Le Provost NMD · TikTok creator

348.0K views on this video

When doing testosterone therapy and using injections, make sure these three things are happening 1. Injection site is always clean (cannot stress this enough!!) 2. You are getting regular blood wo

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the endocrine society 2018 guideline recommends hematocrit monitoring at 3?

The Endocrine Society 2018 guideline recommends hematocrit monitoring at 3 months, 6 months, and annually during testosterone therapy to catch polycythemia early.

What does the video say about home injection infection risk?

Home injection infection risk is real: Fink et al. (2019) identified skin preparation and sterile needle use as under-discussed safety factors in self-administered TRT.

What does the video say about van der nagel et al. (2014) found significant concentration variability?

Van der Nagel et al. (2014) found significant concentration variability and contamination in seized anabolic steroid products, supporting the case against unregulated testosterone sources.

What does the video say about in the us, testosterone?

In the US, testosterone is a Schedule III controlled substance. Obtaining it without a valid prescription from a licensed provider is a legal and safety issue.

What does the video say about compounded testosterone from a 503a pharmacy?

Compounded testosterone from a 503A pharmacy is not FDA-approved and is not equivalent to brand-name pharmaceutical products. Patients should understand this distinction.

What does the video say about estradiol levels warrant monitoring alongside testosterone?

Estradiol levels warrant monitoring alongside testosterone because testosterone aromatizes to estrogen, and imbalances have documented effects on mood, libido, and cardiovascular markers.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr. Le Provost NMD, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.